Enzymatica AB Statistics

Total Valuation

Enzymatica AB has a market cap or net worth of SEK 321.50 million. The enterprise value is 227.11 million.

Market Cap	321.50M
Enterprise Value	227.11M

Important Dates

The next estimated earnings date is Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Enzymatica AB has 215.77 million shares outstanding. The number of shares has increased by 5.39% in one year.

Current Share Class	n/a
Shares Outstanding	215.77M
Shares Change (YoY)	+5.39%
Shares Change (QoQ)	+8.15%
Owned by Insiders (%)	21.18%
Owned by Institutions (%)	0.02%
Float	170.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.83
PB Ratio	1.70
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.21
EV / Sales	5.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.27

Financial Position

The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.01.

Current Ratio	6.08
Quick Ratio	5.49
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-21.43

Financial Efficiency

Return on equity (ROE) is -38.33% and return on invested capital (ROIC) is -21.04%.

Return on Equity (ROE)	-38.33%
Return on Assets (ROA)	-18.52%
Return on Invested Capital (ROIC)	-21.04%
Return on Capital Employed (ROCE)	-27.32%
Revenue Per Employee	2.60M
Profits Per Employee	-3.17M
Employee Count	18
Asset Turnover	0.25
Inventory Turnover	1.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.55% in the last 52 weeks. The beta is 0.04, so Enzymatica AB's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-52.55%
50-Day Moving Average	1.66
200-Day Moving Average	2.12
Relative Strength Index (RSI)	43.72
Average Volume (20 Days)	95,443

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzymatica AB had revenue of SEK 44.25 million and -53.96 million in losses. Loss per share was -0.31.

Revenue	44.25M
Gross Profit	29.36M
Operating Income	-52.13M
Pretax Income	-54.23M
Net Income	-53.96M
EBITDA	-49.05M
EBIT	-52.13M
Loss Per Share	-0.31

Full Income Statement

Balance Sheet

The company has 96.90 million in cash and 2.52 million in debt, giving a net cash position of 94.38 million or 0.44 per share.

Cash & Cash Equivalents	96.90M
Total Debt	2.52M
Net Cash	94.38M
Net Cash Per Share	0.44
Equity (Book Value)	189.49M
Book Value Per Share	0.88
Working Capital	107.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -42.56 million and capital expenditures -530,000, giving a free cash flow of -43.09 million.

Operating Cash Flow	-42.56M
Capital Expenditures	-530,000
Free Cash Flow	-43.09M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross margin is 66.35%, with operating and profit margins of -117.81% and -121.95%.

Gross Margin	66.35%
Operating Margin	-117.81%
Pretax Margin	-122.56%
Profit Margin	-121.95%
EBITDA Margin	-110.85%
EBIT Margin	-117.81%
FCF Margin	n/a

Dividends & Yields

Enzymatica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.39%
Shareholder Yield	-5.39%
Earnings Yield	-16.78%
FCF Yield	-13.40%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a